Abbott has announced that its latest continuous glucose monitor, the FreeStyle Libre 3, is now covered under Medicare. Following news in April that the FDA cleared a separate handheld reader for ...

Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to falsely low glucose readings.

Discover a single device that combines Kindle, Kobo, Libby, Audible, and note-taking capabilities, making it perfect for readers, students, and lifelong learners. Streamline your reading, listening, ...

Abbott is facing a warning letter from FDA regarding its Freestyle Libre family of continuous glucose monitoring (CGM) devices for use in diabetes management. The agency said it received responses ...

Feb 4 (Reuters) - Medical device maker Abbott Laboratories (ABT.N), opens new tab has reported 860 serious injuries linked to the recall of some of its glucose monitoring sensors, the U.S. Food and ...

The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus Sensors by Abbott Diabetes Care due to incorrect glucose readings that are ...

Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM) franchise, FreeStyle Libre. Last October, an agency inspection of ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Abbott Laboratories (NYSE:ABT) received an FDA warning ...

Abbott received a warning letter from the Food and Drug Administration related to its FreeStyle Libre continuous glucose monitors. The warning letter, dated Jan. 23 and posted to the FDA’s website on ...

The sensor for the next-generation FreeStyle Libre 3 CGM is the same size as two U.S. pennies stacked together. [Image courtesy of Abbott] Abbott (NYSE:ABT) is facing an FDA warning letter alleging ...